Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure
書誌事項
- 公開日
- 2005-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- DOI
-
- 10.1016/j.bbrc.2005.10.106
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Biochemical and Biophysical Research Communications
-
Biochemical and Biophysical Research Communications 338 (4), 1865-1874, 2005-12
Elsevier BV